CLINICAL_TRIALS
trial_result
· 2019-06-11
Clinical Trial Update: A Study of Galcanezumab in Participants With Chronic Cluster Headache [Phase 3]
Summary
Phase 3 clinical trial update for galcanezumab in chronic cluster headache completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Chronic Cluster Headache | Phase 3 | Status: COMPLETED | Results posted: 2019-06-11